0

<< Pelvic Inflammatory Disease: Diagnosis and Treatment in the Emergency Department (Pharmacology CME)

References

TOC Will Appear Here

References

References

References

Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.

To help the reader judge the strength of each reference, pertinent information about the study is included in bold type following the reference, where available.

  1. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis. 2005;32(12):778-784. (Retrospective; 770,000 patients)
  2. Rein DB, Kassler WJ, Irwin KL, et al. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol. 2000;95(3):397-402. (Retrospective; 3 years of claims data)
  3. * Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002;186(5):929-937. (Prospective; 831 patients)
  4. Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis. 1983;5(5):876-884. (Retrospective; 232 patients)
  5. Macaluso M, Wright-Schnapp TJ, Chandra A, et al. A public health focus on infertility prevention, detection, and management. Fertil Steril. 2010;93(1):16.e1-e10. (Review)
  6. Eschenbach DA, Wølner-Hanssen P, Hawes SE, et al. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Obstet Gynecol. 1997;89(2):184-192. (Prospective; 155 patients)
  7. * Kahn JG, Walker CK, Washington AE, et al. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA. 1991;266(18):2594-2604. (Systematic review)
  8. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19(4):185-192. (Prospective study; 1800 patients)
  9. Molander P, SjÖberg J, Paavonen J, et al. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol. 2001;17(3):233-238. (Prospective; 30 patients)
  10. Tukeva TA, Aronen HJ, Karjalainen PT, et al. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology. 1999;210(1):209-216. (Prospective; 30 patients)
  11. * Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(3):1-137. (Expert guidelines/systematic review)
  12. UK national guideline for the management of pelvic inflammatory disease 2011. London, UK: British Association for Sexual Health and HIV; June 18, 2011. (Guideline)
  13. Andreotti RF, Lee SI, Dejesus Allison SO, et al. ACR Appropriateness Criteria® acute pelvic pain in the reproductive age group. Ultrasound Q. 2011;27(3):205-210. (Expert guideline)
  14. Rohrbeck P. Pelvic inflammatory disease among female recruit trainees, active component, U.S. armed forces, 2002- 2012. MSMR. 2013;20(9):15-18. (Retrospective; 1500 patients)
  15. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;138(7 Pt 2):880-892. (Retrospective epidemological study)
  16. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol. 2005;106(3):573-580. (Prospective; 831 patients)
  17. Haggerty CL, Totten PA, Astete SG, et al. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2006;2006:30184. (Retrospective; 50 patients)
  18. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol. 2012;206(6):476.e471-e478. (Case-controlled study; 5519 patients)
  19. Clarke LM, Duerr A, Yeung KH, et al. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis. 1997;176(1):286-288. (Prospective; 147 patients)
  20. Cherpes TL, Wiesenfeld HC, Melan MA, et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33(12):747-752. (Retrospective; 736 patients)
  21. Soper DE, Brockwell NJ, Dalton HP. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol. 1992;167(3):653-660. (Prospective; 36 patients)
  22. Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1987;94(5):454-460. (Prospective; 45 patients)
  23. Cho HW, Koo YJ, Min KJ, et al. Pelvic inflammatory disease in virgin women with tubo-ovarian abscess: A single-center experience and literature review. [Epub ahead of print] 7 August 2015. J Pediatr Adolesc Gynecol. (Retrospective; 122 patients)
  24. Goodwin K, Fleming N, Dumont T. Tubo-ovarian abscess in virginal adolescent females: a case report and review of the literature. J Pediatr Adolesc Gynecol. 2013;26(4):e99-e102. (Case report)
  25. Taylor BD, Darville T, Haggerty CL. Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm Dis. 2013;40(2):117-122. (Systematic review)
  26. Yarbrough VL, Winkle S, Herbst-Kralovetz MM. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2015;21(3):353- 377. (Systematic review)
  27. Peter NG, Clark LR, Jaeger JR. Fitz-Hugh-Curtis syndrome: a diagnosis to consider in women with right upper quadrant pain. Cleve Clin J Med. 2004;71(3):233-239. (Review)
  28. Risser WL, Risser JM, Benjamins LJ, et al. Incidence of Fitz- Hugh-Curtis syndrome in adolescents who have pelvic inflammatory disease. J Pediatr Adolesc Gynecol. 2007;20(3):179- 180. (Prospective study; 117 patients presenting to a juvenile detention center)
  29. Schindlbeck C, Dziura D, Mylonas I. Diagnosis of pelvic inflammatory disease (PID): intra-operative findings and comparison of vaginal and intra-abdominal cultures. Arch Gynecol Obstet. 2014;289(6):1263-1269. (Retrospective; 73 patients)
  30. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obstet Gynecol. 2012;55(4):893-903. (Review)
  31. Cohen CR, Sinei S, Reilly M, et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis. 1998;178(5):1352-1358. (Prospective; 133 patients)
  32. Wiesenfeld HC, Sweet RL, Ness RB, et al. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis. 2005;32(7):400-405. (Retrospective; 1293 patients)
  33. Hadgu A, Westrom L, Brooks CA, et al. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol. 1986;155(5):954-960. (Retrospective; 629 patients)
  34. Marks C, Tideman RL, Estcourt CS, et al. Assessment of risk for pelvic inflammatory disease in an urban sexual health population. Sex Transm Infect. 2000;76(6):470-473. (Retrospective; 741 patients)
  35. Blake DR, Fletcher K, Joshi N, et al. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol. 2003;16(1):25-30. (Retrospective; 193 patients)
  36. Amman R, Zehender O, Jenny S, et al. [Acute gonococcal perihepatitis (Fitz-Hugh-Curtis syndrome). An acute, right-side “pleuritic-peritonitic” upper abdominal pain syndrome in Adnexitis gonorrhoica: diagnosis by laparoscopy]. Dtsch Med Wochenschr. 1971;96(39):1515-1519. (Case series; 5 patients)
  37. Gatt D, Jantet G. Perisplenitis and perinephritis in the Curtis- Fitz-Hugh syndrome. Br J Surg. 1987;74(2):110-112. (Case series; 4 patients)
  38. Lopez-Zeno JA, Keith LG, Berger GS. The Fitz-Hugh-Curtis syndrome revisited. Changing perspectives after half a century. J Reprod Med. 1985;30(8):567-582. (Systematic review)
  39. Kim HY, Yang JI, Moon C. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess. J Obstet Gynaecol Res. 2015;41(5):742-746. (Retrospective; 458 patients)
  40. Rothman KJ, Lanza L, Lal A, et al. Incidence of pelvic inflammatory disease among women treated for gonorrhea or chlamydia. Pharmacoepidemiol Drug Saf. 1996;5(6):409-414. (Retrospective; 254 patients)
  41. Kerani RP, Stenger MR, Weinstock H, et al. Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012. Sex Transm Dis. 2015;42(1):6-12. (Prospective; 44,144 isolates)
  42. Gullberg E, Cao S, Berg OG, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7(7):e1002158. (Review)
  43. Kimani J, Maclean IW, Bwayo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis. 1996;173(6):1437- 1444. (Prospective; 302 patients)
  44. Elizur SE, Lebovitz O, Weintraub AY, et al. Pelvic inflammatory disease in women with endometriosis is more severe than in those without. Aust N Z J Obstet Gynaecol. 2014;54(2):162-165. (Retrospective; 174 patients)
  45. Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res. 1997;23(5):421-426. (Retrospective; 6557 patients)
  46. Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA. 1991;266(18):2574-2580. (Meta-analysis)
  47. Scholes D, Daling JR, Stergachis A, et al. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol. 1993;81(4):601-606. (Retrospective; 131 patients)
  48. Gareen IF, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology. 2000;11(5):589-597. (Meta-analysis from 1974-1990)
  49. Walsh T, Grimes D, Frezieres R, et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet. 1998;351(9108):1005- 1008. (Prospective; 1984 patients)
  50. Birgisson NE, Zhao Q, Secura GM, et al. Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users. J Womens Health (Larchmt). 2015;24(5):354-359. (Prospective; 9000 patients)
  51. Cox C, McKenna JP, Watt AP, et al. Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting. Int J STD AIDS. 2016;27(10):861- 867. (Prospective; 165 patients)
  52. Kirkcaldy RD, Soge O, Papp JR, et al. Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. Antimicrob Agents Chemother. 2015;59(2):998-1003. (Prospective; 45,000 isolates)
  53. Li M, McDermott R. Smoking, poor nutrition, and sexually transmitted infections associated with pelvic inflammatory disease in remote North Queensland indigenous communities, 1998-2005. BMC Womens Health. 2015;15:31. (Retrospective; 1445 patients)
  54. * Ness RB, Smith KJ, Chang CC, et al. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis. 2006;33(3):137-142. (Prospective; 1170 patients)
  55. Scholes D, Daling JR, Stergachis AS. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health. 1992;82(10):1352-1355. (Retrospective; 131 patients)
  56. Umbricht-Schneiter A, Santora P, Moore RD. Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. Am J Med. 1991;91(2):110-118. (Prospective; 1964 patients)
  57. Jamieson DJ, Duerr A, Macasaet MA, et al. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2000;8(2):88-93. (Prospective; 349 patients)
  58. Champion JD, Shain RN, Piper J. Minority adolescent women with sexually transmitted diseases and a history of sexual or physical abuse. Issues Ment Health Nurs. 2004;25(3):293- 316. (Prospective; 30 patients)
  59. Glaser D. Treatment issues in child sexual abuse. Br J Psychiatry. 1991;159:769-782. (Review)
  60. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med. 1986;104(2):187-193. (Prospective; 36 patients)
  61. Simms I, Warburton F, Westrom L. Diagnosis of pelvic inflammatory disease: time for a rethink. Sex Transm Infect. 2003;79(6):491-494. (Retrospective; 623 patients)
  62. Slap GB, Forke CM, Cnaan A, et al. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health. 1996;18(6):397-403. (Retrospective; 208 patients)
  63. Wagner A, Russell C, Ponterio JM, et al. Ruptured tuboovarian abscess and septic shock with Clostridium perfringens in a postmenopausal woman: a case report. J Reprod Med. 2009;54(10):652-654. (Case report)
  64. Westfall MD, Lumpkin J. A 33-year-old white female with abdominal pain, nausea, vomiting and hypotension. J Emerg Med. 1993;11(3):271-273. (Case report)
  65. Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol. 2001;184(5):856- 863. (Retrospective; 651 patients)
  66. Litt IF, Cohen MI. Perihepatitis associated with salpingitis in adolescents. JAMA. 1978;240(12):1253-1254. (Retrospective; 137 patients)
  67. Fitz-Hugh T. Acute gonococcic peritonitis of the right upper quadrent in women. JAMA. 1934;102(25):2094-2096. (Case series; 3 patients)
  68. Adhikari S, Blaivas M, Lyon M. Role of bedside transvaginal ultrasonography in the diagnosis of tubo-ovarian abscess in the emergency department. J Emerg Med. 2008;34(4):429-433. (Retrospective; 20 patients)
  69. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med. 1984;311(1):1-6. (Prospective; 100 patients)
  70. Shrier LA, Dean D, Klein E, et al. Limitations of screening tests for the detection of Chlamydia trachomatis in asymptomatic adolescent and young adult women. Am J Obstet Gynecol. 2004;190(3):654-662. (Prospective; 139 women)
  71. Shafer MA, Moncada J, Boyer CB, et al. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol. 2003;41(9):4395-4399. (Prospective; 2157 patients)
  72. Zakher B, Cantor AG, Pappas M, et al. Screening for gonorrhea and chlamydia: a systematic review for the U.S. Preventive Services Task Force screening for gonorrhea and chlamydia. Ann Intern Med. 2014;161(12):884-893. (Systematic review)
  73. Van Der Pol B, Liesenfeld O, Williams JA, et al. Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2012;50(7):2244- 2249. (Prospective; 4316 samples)
  74. Van Der Pol B, Taylor SN, Lebar W, et al. Clinical evaluation of the BD ProbeTec Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper system with XTR technology. Sex Transm Dis. 2012;39(2):147-153. (Prospective; 1768 patients)
  75. Schoeman SA, Stewart CM, Booth RA, et al. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ. 2012;345:e8013. (Prospective; 3973 patients)
  76. Chernesky M, Jang D, Gilchrist J, et al. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs. J Clin Microbiol. 2014;52(7):2305-2310. (Prospective; 575 patients)
  77. Berwald N, Cheng S, Augenbraun M, et al. Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department. Acad Emerg Med. 2009;16(4):360- 363. (Prospective; 162 patients)
  78. Risser JM, Risser WL. Purulent vaginal and cervical discharge in the diagnosis of pelvic inflammatory disease. Int J STD AIDS. 2009;20(2):73-76. (Systematic review)
  79. Singh D, Marrazzo JM. Screening and management of genital chlamydial infections. Infect Dis Clin North Am. 2013;27(4):739-753. (Review)
  80. Griffith WF, Stuart GS, Gluck KL, et al. Vaginal speculum lubrication and its effects on cervical cytology and microbiology. Contraception. 2005;72(1):60-64. (Prospective; 6538 patients)
  81. Rabe LK, Hillier SL. Effect of chlorhexidine on genital microflora, Neisseria gonorrhoeae, and Trichomonas vaginalis in vitro. Sex Transm Dis. 2000;27(2):74-78. (In vitro study)
  82. Lampe MF, Ballweber LM, Stamm WE. Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel. Antimicrob Agents Chemother. 1998;42(7):1726-1730. (In vitro study)
  83. Webster LA, Berman SMB, Greenspan JR. Surveillance for gonorrhea and primary and secondary syphilis among adolescents, U.S. 1981-1991. MMWR CDC Surveill Summ. 1993;42(SS-3):1-11. (Retrospective; health department reports 1981-1991)
  84. Tomas ME, Getman D, Donskey CJ, et al. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol. 2015;53(8):2686-2692. (Prospec tive; 264 patients)
  85. Bevan CD, Johal BJ, Mumtaz G, et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol. 1995;102(5):407-414. (Prospective; 147 patients)
  86. Demirtas O, Akman L, Demirtas GS, et al. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience. Arch Gynecol Obstet. 2013;287(3):519-523. (Retrospective; 73 patients)
  87. Lee MH, Moon MH, Sung CK, et al. CT findings of acute pelvic inflammatory disease. Abdom Imaging. 2014;39(6):1350- 1355. (Prospective; 231 patients)
  88. You JS, Kim MJ, Chung HS, et al. Clinical features of Fitz- Hugh-Curtis syndrome in the emergency department. Yonsei Med J. 2012;53(4):753-758. (Retrospective; 82 patients)
  89. Romosan G, Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet. 2014;289(4):705-714. (Systematic review)
  90. Timor-Tritsch IE, Lerner JP, Monteagudo A, et al. Transvagi-nal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol. 1998;12(1):56-66. (Prospective; 77 patients)
  91. Molander P, Finne P, Sjöberg J, et al. Observer agreement with laparoscopic diagnosis of pelvic inflammatory disease using photographs. Obstet Gynecol. 2003;101(5 Pt 1):875-880. (Prospective; 6 patients)
  92. Polena V, Huchon C, Varas Ramos C, et al. Non-invasive tools for the diagnosis of potentially life-threatening gynaecological emergencies: a systematic review. PLoS One. 2015;10(2):e0114189. (Systematic review)
  93. Sam JW, Jacobs JE, Birnbaum BA. Spectrum of CT findings in acute pyogenic pelvic inflammatory disease. Radiographics. 2002;22(6):1327-1334. (Review)
  94. Jung SI, Kim YJ, Park HS, et al. Acute pelvic inflammatory disease: diagnostic performance of CT. J Obstet Gynaecol Res. 2011;37(3):228-235. (Prospective study with 2 radiologists)
  95. Li W, Zhang Y, Cui Y, et al. Pelvic inflammatory disease: evaluation of diagnostic accuracy with conventional MR with added diffusion-weighted imaging. Abdom Imaging. 2013;38(1):193-200. (Prospective; 187 patients)
  96. Eckert LO, Hawes SE, Wolner-Hanssen PK, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol. 2002;186(4):690-695. (Prospective; 152 patients)
  97. Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol. 1991;164(1 Pt 1):113-120. (Prospective; 95 patients)
  98. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007;136(3):340-347. (Meta-analysis)
  99. Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res. 2003;31(1):45-54. (Retrospective; 309 patients)
  100. Savaris RF, Teixeira LM, Torres TG, et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol. 2007;110(1):53-60. (Retrospective; 133 patients)
  101. McGregor JA, Crombleholme WR, Newton E, et al. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol. 1994;83(6):998-1004. (Retrospective; 207 patients)
  102. Acquavella AP, Rubin A, D’Angelo LJ. The coincident diagnosis of pelvic inflammatory disease and pregnancy: are they compatible? J Pediatr Adolesc Gynecol. 1996;9(3):129-132. (Retrospective; 1205 patients)
  103. Blanchard AC, Pastorek JG 2nd, Weeks T. Pelvic inflammatory disease during pregnancy. South Med J. 1987;80(11):1363- 1365. (Case series; 3 patients)
  104. Silva MJ, Florencio GL, Gabiatti JR, et al. Perinatal morbidity and mortality associated with chlamydial infection: a meta-analysis study. Braz J Infect Dis. 2011;15(6):533-539. (Meta-analysis)
  105. Acs N, Banhidy F, Puho EH, et al. Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: a population-based case-control study. Birth Defects Res A Clin Mol Teratol. 2008;82(8):563-570. (Retrospective; 195 patients)
  106. Carter TC, Olney RS, Mitchell AA, et al. Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2011;91(2):108-116. (Retrospective; 12,158 patients)
  107. Ward K, Theiler RN. Once-daily dosing of gentamicin in obstetrics and gynecology. Clin Obstet Gynecol. 2008;51(3):498- 506. (Systematic review)
  108. Czeizel AE, Rockenbauer M, Olsen J, et al. A teratological study of aminoglycoside antibiotic treatment during preg-nancy. Scand J Infect Dis. 2000;32(3):309-313. (Retrospective; 22,965 patients)
  109. Kirkwood A, Harris C, Timar N, et al. Is gentamicin ototoxic to the fetus? J Obstet Gynaecol Can. 2007;29(2):140-145. (Retrospective; 52 patients)
  110. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol. 1997;89(4):524-528. (Retrospective; 18,515 patients)
  111. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol. 2009;23(1):18-28. (Retrospective; 30,049 patients)
  112. Lee V, Tobin JM, Foley E. Relationship of cervical ectopy to chlamydia infection in young women. J Fam Plann Reprod Health Care. 2006;32(2):104-106. (Prospective; 231 patients)
  113. Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol. 2006;18(5):503-510. (Review)
  114. Mugo NR, Kiehlbauch JA, Nguti R, et al. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet Gynecol. 2006;107(4):807-812. (Prospective; 148 patients)
  115. Tepper NK, Steenland MW, Gaffield ME, et al. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception. 2013;87(5):655-660. (Systematic review)
  116. U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013;62(RR-5):1-60. (Guidelines)
  117. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis. 2005;41(5):623-629. (Prospective; 977 patients)
  118. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352(7):676-685. (Prospective; 931 patients)
  119. Goyal M, Hersh A, Luan X, et al. National trends in pelvic inflammatory disease among adolescents in the emergency department. J Adolesc Health. 2013;53(2):249-252. (Retrospective NAHMCS database study)
  120. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418-426. (Meta-analysis)
  121. Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health. 2007;97(6):1118-1125. (Prospective; 14,322 patients)
  122. Walker J, Fairley CK, Bradshaw CS, et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin Infect Dis. 2013;56(8):1094-1100. (Prospective; 119 patients)
  123. Vandepitte J, Weiss HA, Kyakuwa N, et al. Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis. 2013;40(5):422- 427. (Prospective; 119 patients)
  124. Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect. 2008;84(5):338-342. (Prospective; 682 patients)
  125. Lau A, Bradshaw CS, Lewis D, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1389-1399. (Meta-analysis)
  126. Bradshaw CS, Chen MY, Fairley CK. Persistence of Myco-plasma genitalium following azithromycin therapy. PLoS One. 2008;3(11):e3618. (Prospective; 8450 patients)
  127. Mikamo H, Iwasaku K, Yamagishi Y, et al. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women. J Infect Chemother. 2014;20(7):429-435. (Prospective; 60 patients)
  128. Piyadigamage A, Wilson J. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy. Sex Transm Infect. 2005;81(3):233-235. (Prospective; 147 patients)
  129. Haggerty CL, Hillier SL, Bass DC, et al. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004;39(7):990-995. (Prospective; 278 patients)
  130. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther. 2011;9(1):61-70. (Review)
  131. Ross JD, Cronje HS, Paszkowski T, et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect. 2006;82(6):446-451. (Prospective; 741 patients)
  132. Malhotra M, Sharma JB, Batra S, et al. Ciprofloxacin-tinidazole combination, fluconazole-azithromicin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. Indian J Med Sci. 2003;57(12):549-555. (Prospective; 165 patients)
  133. Dunbar-Jacob J, Sereika SM, Foley SM, et al. Adherence to oral therapies in pelvic inflammatory disease. J Womens Health (Larchmt). 2004;13(3):285-291. (Prospective; 91 patients)
  134. Kidd S, Moore PC, Kirkcaldy RD, et al. Comparison of antimicrobial susceptibility of urogenital Neisseria gonorrhoeae isolates obtained from women and men. Sex Transm Dis. 2015;42(8):434-439. (Prospective; 478 patients)
  135. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother. 2010;65(10):2141-2148. (Retrospective; 10,002 patients)
  136. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17(1):148- 149. (Case report)
  137. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56(3):1273-1280. (Case report)
  138. Watchirs Smith LA, Hillman R, Ward J, et al. Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics. Sex Transm Infect. 2013;89(4):320-326. (Systematic review)
  139. van Dommelen L, van Tiel FH, Ouburg S, et al. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect. 2010;86(5):355-359. (Prospective; 772 patients)
  140. Tabrizi SN, Unemo M, Golparian D, et al. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol. 2013;51(6):1945-1947. (In vitro study)
  141. Guy RJ, Natoli L, Ward J, et al. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the “TTANGO” trial protocol. BMC Infect Dis. 2013;13:485. (Brief report on a study protocol)
  142. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland. 2003. (Guideline)
  143. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis. 2009;36(8):478-489. (Systematic review)

 

Publication Information
Authors

Charles Walter Bugg, MD, PhD;Taku Taira, MD

Publication Date

December 1, 2016

CME Expiration Date

January 1, 2020

CME Credits

4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits.
Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits

Get Permission

CME Information

Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.